Tudor Investment Corp
ARQT icon

Tudor Investment Corp’s Arcutis Biotherapeutics ARQT Stock Holding History

Tudor Investment Corp’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-106,134
Closed -$3.08M – 3600
2025
Q4 		$3.08M Buy
106,134
+36,154
+52% +$926K 0.02% 1487
2025
Q3 		$1.32M Buy
+69,980
New +$1.1M 0.01% 2077
2025
Q2 		– Sell
-103,373
Closed -$1.62M – 3242
2025
Q1 		$1.62M Buy
103,373
+39,039
+61% +$550K 0.01% 1489
2024
Q4 		$896K Buy
64,334
+43,370
+207% +$475K 0.01% 1806
2024
Q3 		$195K Buy
+20,964
New +$207K ﹤0.01% 2544
2024
Q2 		– Sell
-204,779
Closed -$2.03M – 2311
2024
Q1 		$2.03M Buy
+204,779
New +$1.53M 0.02% 1016
2023
Q4 		– Sell
-45,461
Closed -$241K – 2364
2023
Q3 		$241K Buy
+45,461
New +$387K ﹤0.01% 2018
2023
Q2 		– Sell
-30,306
Closed -$333K – 2426
2023
Q1 		$333K Buy
+30,306
New +$438K 0.01% 1857
2022
Q4 		– Sell
-18,349
Closed -$351K – 2368
2022
Q3 		$351K Buy
+18,349
New +$416K 0.01% 1671

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return